NewAmsterdam Pharma Company N.V.
HealthcareNASDAQ:NAMS · NASDAQ Capital Market
+$0.14 today
Vol 0.67M · Avg 1.21M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+50.42%
Period High
$41.45
Period Low
$17.96
Latest
$30.40
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Kymera Therapeutics, Inc.
NASDAQ:KYMR
$7.09B
Immunovant, Inc.
NASDAQ:IMVT
$6.90B
Arcellx, Inc.
ACLX
$6.73B
Praxis Precision Medicines, Inc.
NASDAQ:PRAX
$5.64B
CG Oncology, Inc. Common stock
NASDAQ:CGON
$5.25B
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
$5.12B
Akero Therapeutics, Inc.
AKRO
$4.50B
Crinetics Pharmaceuticals, Inc.
NASDAQ:CRNX
$3.63B
Viking Therapeutics, Inc.
NASDAQ:VKTX
$3.34B
Soleno Therapeutics, Inc.
SLNO
$2.76B
What is the latest NAMS filing?
The latest filing shown is S-8 dated Jun 5, 2026.
How many recent filings does NAMS have?
Intrinsic Alpha currently shows 20 recent filings for NAMS.
Explore More
Continue the stock analysis
Jump to another research area for this company.